What are the targeted therapeutic drugs for colorectal cancer and gastric cancer

Targeted treatment drugs for colorectal cancer and gastric cancer: "The introduction of oral targeted chemotherapy drugs has changed the lives of tens of thousands of cancer patients and is a huge breakthrough in cancer treatment in China," said authoritative experts in breast cancer, colorectal cancer and gastric cancer from across the country.

Experts said: "Oral targeted chemotherapy drugs not only significantly prolong the survival of cancer patients, but also effectively improve the quality of life of patients due to their low toxicity and side effects." Eight years ago, once cancer patients started chemotherapy, they would suffer from hair loss, weight loss, frequent vomiting and other conditions, and the strong toxicity and side effects made patients live a life worse than death. With the launch of the oral targeted chemotherapy drug capecitabine (Xeloda), patients can take it orally at home, eliminating the need to travel back and forth, and can also avoid other adverse reactions and phlebitis caused by long-term injections. The quality of life of cancer patients living with cancer has been significantly improved, and patients with colorectal cancer, breast cancer and gastric cancer have benefited from this.
When asked, "Which is better, oral chemotherapy or intravenous chemotherapy?", a senior professor said: Many people mistakenly believe that oral chemotherapy is not as good as intravenous chemotherapy, which is wrong! As a new and highly effective oral chemotherapy drug, capecitabine, as an oral targeted chemotherapy drug, has a unique mechanism of action of intratumoral activation, which increases the concentration of 5-fluorouracil, which has a killing effect on tumors, in tumor tissues, directly acts on tumor tissues, making it have a more direct tumor killing effect and better safety. At the same time, because it is an oral chemotherapy drug, it avoids the inconvenience and burden brought by traditional intravenous injection treatment, because there is no need to use the insertion of intravenous catheters, thus avoiding various complications and sequelae such as phlebitis caused by it, which are difficult for patients to accept. Oral chemotherapy drugs not only provide convenience and reduce side effects, but more importantly, this convenience is based on high efficiency. The latest research shows that the chemotherapy regimen containing the oral targeted chemotherapy drug Xeloda is more effective than the chemotherapy regimen of intravenous injection of 5-fluorouracil.